Camarda Financial Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Healthcare ETF
IYH
|
+$14.1M |
| 2 |
Eli Lilly
LLY
|
+$3.27M |
| 3 |
IBM
IBM
|
+$2.98M |
| 4 |
General Dynamics
GD
|
+$2.97M |
| 5 |
Gilead Sciences
GILD
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Financials ETF
IYF
|
+$13.6M |
| 2 |
Idexx Laboratories
IDXX
|
+$3.26M |
| 3 |
Oracle
ORCL
|
+$2.91M |
| 4 |
Palantir
PLTR
|
+$2.78M |
| 5 |
Costco
COST
|
+$2.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.1% |
| 2 | Healthcare | 5.92% |
| 3 | Communication Services | 4.07% |
| 4 | Financials | 2.78% |
| 5 | Consumer Discretionary | 2.6% |
Similar funds
Camarda Financial Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Camarda Financial Advisors held 122 positions worth $263M, down 3.2% from $271M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Camarda Financial Advisors withdrew a net $20.5M in Q4 2025, closing 20 positions and reducing 70 holdings. Its most notable exit was iShares US Financials ETF, an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Camarda Financial Advisors opened a new position in iShares US Healthcare ETF worth $14.6M.
- Camarda Financial Advisors's largest Q4 2025 buy was iShares US Healthcare ETF: 223,592 shares worth $14.6M.
- Camarda Financial Advisors added most to IBM in Q4 2025, an estimated $2.98M increase.
- Camarda Financial Advisors's biggest Q4 2025 reduction was Palantir, cutting an estimated $2.78M.
- Camarda Financial Advisors fully exited iShares US Financials ETF in Q4 2025, selling an estimated $13.6M.
- Camarda Financial Advisors's ten largest holdings make up 37% of its $263M portfolio in Q4 2025.
- Camarda Financial Advisors opened 11 new positions and closed 20 in Q4 2025.
- Camarda Financial Advisors's portfolio value fell 3.2% quarter-over-quarter to $263M.
Based on Camarda Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.